Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2022 Results Report

Rhea-AI Summary

Progyny, Inc. (PGNY), a leading fertility benefits management company, will announce its financial results for the fourth quarter and full year ended December 31, 2022, after market close on February 27, 2023. A conference call will be held at 4:45 PM ET for investors to discuss these results, with a press release issued prior to the call. Interested parties can join via the provided dial-in numbers. An audio replay will be available until March 6, 2023. Progyny aims to redefine fertility solutions, showcasing the value of comprehensive benefits for employers, patients, and healthcare professionals.

Positive

• The upcoming financial results announcement may indicate a positive trajectory for the company.
• Progyny's solutions are recognized for reducing healthcare costs for employers, suggesting strong customer demand.

Negative

• None.

NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period and full year ended December 31, 2022 after the close of the market on Monday, February 27, 2023.

The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.

Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.

An audio replay of the call will be available through Monday, March 6, 2023 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.

A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.

About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians. 

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com

FAQ

When will Progyny report its financial results for Q4 2022?

Progyny will report its financial results on February 27, 2023.

What time will Progyny's conference call take place?

The conference call will occur at 4:45 PM Eastern Time on February 27, 2023.

How can I access the replay of Progyny's conference call?

The replay can be accessed until March 6, 2023, by calling the provided numbers with the passcode 265484.

What does Progyny specialize in?

Progyny specializes in fertility benefits management solutions.